Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2000

View Archived Issues

Progenics and Cytogen present preclinical progress on PSMA technology

M-Vax shown to induce T-cell-mediated immune reactions in metastatic melanoma study

Oxford GlycoSciences and Pfizer file patent application for AD markers

New program for bone disease therapy initiated by Aastrom Biosciences

Sonus signs agreement with SUNY to develop oxygen delivery systems

Positive results reported for Reminyl in AD therapy

CollaGenex research reported at international dental meeting

Zadaxin plus chemotherapy shows promise in malignant melanoma

Gemini Genomics and Kyowa Hakko discover novel gene for metabolic syndrome

Bayer obtains first approval worldwide for new antiallergic agent

Glaxo Wellcome continues research on formamides as inhibitors of MMPs and/or TNF-alpha release

Formamides from Glaxo Wellcome with potential as antitumor therapeutics

LeukoSite and Kyowa Hakko collaborate on the design of chemokine receptor antagonists

New formulation of Hectorol approved by FDA

Inhibitors of PDE5 claimed in recent patent by Tanabe Seiyaku

Preclinical study suggests potential for Axonyx compounds in AD

FDA committee favors approval of new oral treatment for ED

Novel antidiabetics from Novo Nordisk act as normoglycemic agents

Prosorba Column launched in Europe for RA

New antitumor tetrocarcin derivatives in early development at Japanese lab

Pfizer describes SAR in a series of quinazolinone AMPA antagonists at ACS meeting

Another setback reported in the elusive search for an effective sepsis therapy

BMS-184476 and BMS-188797 covered at ACS/AACR meetings; BMS reveals structures

SuperGen and AVI BioPharma establish marketing agreement for Avicine

Potent and selective oxindole cdk2 inhibitors display dual antitumor and chemoprotective effects

Rasagiline successfully completes phase III trial in PD

Selective inhibitor of chitin II synthase discovered in Korea and evaluated as antifungal agent

Apligraf PMA supplement tentatively scheduled for FDA review in May

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026